Combination of hydroquinone and fractional CO2 laser versus hydroquinone monotherapy in melasma treatment: A randomized, single-blinded, split-face clinical trial | Zendy

Farahnaz Fatemi Naeini | Zendy; Sanaz Nourmohammadi Abadchi | Zendy; Elham Beheshtian | Zendy

Open Access

Combination of hydroquinone and fractional CO₂ laser versus hydroquinone monotherapy in melasma treatment: A randomized, single-blinded, split-face clinical trial

Author(s) -

Farahnaz Fatemi Naeini,

Sanaz Nourmohammadi Abadchi,

Elham Beheshtian

Publication year - 2019

Publication title -

indian journal of dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.395

H-Index - 36

eISSN - 1998-3611

pISSN - 0019-5154

DOI - 10.4103/ijd.ijd_240_17

Subject(s) - melasma , medicine , hyperpigmentation , hydroquinone , randomized controlled trial , laser therapy , combination therapy , patient satisfaction , clinical trial , blinded study , dermatology , clinical study , laser , surgery , chemistry , physics , organic chemistry , optics

Melasma is a chronic hyperpigmentation skin disorder mainly affecting women in the reproductive age. Available treatments for melasma do not lead to long-term satisfactory results.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research